WINRHO.COM: Keyword Density Checker

Total words: 2819 | 2-word phrases: 736 | 3-word phrases: 828 | 4-word phrases: 857

PAGE INFO

Title	Try to keep the title under 60 characters (70 characters) WinRho SDF for the treatment of immune thrombocytopenic purpura (ITP).
Description	Try to keep the meta description between 50 - 160 characters (169 characters) Learn about WinRho® SDF [Rho(D) Immune Globulin Intravenous (Human)] for the treatment of adult & pediatric patients with immune thrombocytopenic purpura (ITP).
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (10 characters) References

#	Keyword	Frequency	Density
1	important safety information	5	0.60%
2	the treatment of	4	0.48%
3	in the treatment	4	0.48%
4	rhod immune globulin	4	0.48%
5	with winrho® sdf	3	0.36%
6	symptoms of ivh	3	0.36%
7	of winrho® sdf	3	0.36%
8	in the united	3	0.36%
9	in patients who	3	0.36%
10	immune globulin intravenous	3	0.36%
11	the united states	3	0.36%
12	andor symptoms of	2	0.24%
13	clinical trials for	2	0.24%
14	evaluated in clinical	2	0.24%
15	in clinical trials	2	0.24%
16	glucose levels in	2	0.24%
17	trials for patients	2	0.24%
18	been evaluated in	2	0.24%
19	not been evaluated	2	0.24%
20	have not been	2	0.24%
21	the safety and	2	0.24%
22	health care provider	2	0.24%
23	safety and efficacy	2	0.24%
24	and efficacy of	2	0.24%
25	signs andor symptoms	2	0.24%
26	causes of thrombocytopenia	2	0.24%
27	for patients with	2	0.24%
28	winrho® sdf for	2	0.24%
29	is intended for	2	0.24%
30	who are rhodnegative	2	0.24%

#	Keyword	Frequency	Density
1	in the treatment of	4	0.47%
2	in the united states	3	0.35%
3	been evaluated in clinical	2	0.23%
4	following rhod immune globulin	2	0.23%
5	the safety and efficacy	2	0.23%
6	or in previously splenectomized	2	0.23%
7	thrombocytopenia or in previously	2	0.23%
8	of thrombocytopenia or in	2	0.23%
9	causes of thrombocytopenia or	2	0.23%
10	trials for patients with	2	0.23%
11	signs andor symptoms of	2	0.23%
12	clinical trials for patients	2	0.23%
13	in clinical trials for	2	0.23%
14	evaluated in clinical trials	2	0.23%
15	not been evaluated in	2	0.23%
16	have not been evaluated	2	0.23%
17	and efficacy of winrho®	2	0.23%
18	andor symptoms of ivh	2	0.23%
19	rhod immune globulin intravenous	2	0.23%
20	in patients who are	2	0.23%
21	the treatment of itp	2	0.23%
22	safety and efficacy of	2	0.23%
23	patients who are rhodnegative	2	0.23%
24	adults with chronic itp	1	0.12%
25	rhodpositive children with chronic	1	0.12%
26	prevent excessive hemorrhage in	1	0.12%
27	infection the safety and	1	0.12%
28	hiv infection the safety	1	0.12%
29	to hiv infection the	1	0.12%
30	secondary to hiv infection	1	0.12%
31	excessive hemorrhage in the	1	0.12%
32	hemorrhage in the treatment	1	0.12%
33	itp secondary to hiv	1	0.12%
34	occur in the spleen	1	0.12%
35	nonsplenectomized rhodpositive children with	1	0.12%
36	red blood cell destruction	1	0.12%
37	children with chronic or	1	0.12%
38	itp adults with chronic	1	0.12%
39	with chronic itp children	1	0.12%
40	site is intended for	1	0.12%

#	URL	Whois	Check
1	http://www.emergentbiosolutions.com	Whois	emergentbiosolutions.com
2	https://www.kamada.com/	Whois	kamada.com
3	https://www.kamada.com/privacy-policy/	Whois	kamada.com
4	https://www.kamada.com/contact-us/	Whois	kamada.com
5	https://www.kamada.com/privacy-policy/	Whois	kamada.com
6	https://www.kamada.com/contact-us/	Whois	kamada.com